Screening for glaucoma: comparative effectiveness

Ervin AM, Boland MV, Myrowitz EH, Prince J, Hawkins B, Vollenweider D, Ward D, Suarez-Cuervo C, Robinson KA
Record ID 32013000187
English
Authors' objectives: Open-angle glaucoma (OAG) is the most common form of progressive optic neuropathy, and it is estimated that more than half of those who have glaucoma are undiagnosed. The objective of this review was to assess the effect of screening for OAG. We also summarized the accuracy of diagnostic tests.
Authors' recommendations: We did not identify any systematic review or study that provided evidence for direct or indirect links between glaucoma screening and visual field loss, visual impairment, optic nerve damage, intraocular pressure, or patient-reported outcomes. Early treatment is important in determining the indirect chain of evidence for screening; the treatment of glaucoma is addressed in the report Treatment for Glaucoma: Comparative Effectiveness. There have been improvements in screening devices, yet there is limited evidence on the effects of screening for OAG.
Details
Project Status: Completed
URL for project: https://effectivehealthcare.ahrq.gov/products/glaucoma-screening/research
Year Published: 2012
URL for published report: https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research.pdf
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Glaucoma, Open-Angle
  • Diagnostic Screening Programs
  • Vision Screening
Contact
Organisation Name: Agency for Healthcare Research and Quality
Contact Address: Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name: martin.erlichman@ahrq.hhs.gov
Contact Email: martin.erlichman@ahrq.hhs.gov
Copyright: Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.